Drug: Creon 10

CREON® 10 Capsules are orally administered and contain pancrelipase (lipase 10,000 USP Units, protease 37,500 USP Units, and amylase 33,200 USP Units per capsule) which is of porcine pancreatic origin. Each CREON 10 (pancrelipase delayed-released capsules) Capsule is filled with 249 mg of delayed-release MINIMICROSPHERES®. Inactive ingredients include dibutyl phthalate, dimethicone, hydroxypropylmethylcellulose phthalate, light mineral oil and polyethylene glycol. The capsule shells contain black iron oxide, gelatin, red iron oxide, titanium dioxide, and yellow iron oxide. The capsule imprinting ink contains dimethicone, 2-ethoxyethanol, shellac, soya lecithin, and titanium dioxide.

Source: http://www.rxlist.com

The most frequently reported adverse reactions to pancreatic enzyme-containing products are gastrointestinal in nature which may include nausea, vomiting, bloating, cramping, constipation or diarrhea. Less frequently, allergic-type reactions have also been observed. Very high doses of pancreatin have been associated with hyperuricosuria and hyperuricemia. Read the Creon 10 (pancrelipase delayed-released capsules) Side Effects Center for a complete guide to possible side effectsLearn More »

Source: http://www.rxlist.com

Clinical experience should dictate initial starting dose. Doses should be taken during meals or snacks, not before or after. Do not take without food. Adults and Children Over 6 Years Old Usual initial starting dosage is one to two CREON 10 (pancrelipase delayed-released capsules) Capsules per meal or snack. Children Under 6 Years Old Usual initial starting dosage is up to one CREON 10 (pancrelipase delayed-released capsules) Capsule per meal or snack. For cystic fibrosis patients, typical doses are 1,500 - 3,000 USP lipase units/kg/meal. Dosage should be adjusted according to the severity of the disease, control of steatorrhea and maintenance of good nutritional status. Doses in excess of 6,000 USP lipase units/kg/meal are not recommended. Dose increases, if required, should occur with careful monitoring of body weight and stool fat content. When changing strengths of pancreatic enzyme products, care should be taken to maintain equivalent lipase units for each divided dosage. It is important to ensure adequate hydration of patients at all times while taking pancreatic enzymes. Where swallowing of capsules is difficult, the capsules may be carefully opened and the MINIMICROSPHERES added to a small amount of soft food, with a pH less than 5.5. The soft food should be swallowed immediately without chewing and followed with a glass of water or juice to insure swallowing.

Source: http://www.rxlist.com

No information provided. Read the Creon 10 Drug Interactions Center for a complete guide to possible interactions Learn More »

Source: http://www.rxlist.com

CREON 10 (pancrelipase delayed-released capsules) Capsules are indicated for patients with pancreatic exocrine insufficiency as is often associated with:
  • cystic fibrosis
  • chronic pancreatitis
  • post-pancreatectomy
  • post-gastrointestinal bypass surgery (e.g., Billroth II gastroenterostomy)
  • ductal obstruction from neoplasm (e.g., of the pancreas or common bile duct)

Source: http://www.rxlist.com

CREON 10 (pancrelipase delayed-released capsules) Capsules are contraindicated in the early stages of acute pancreatitis or in patients who are known to be hypersensitive to pork protein. Last reviewed on RxList: 9/29/2008
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

No information provided.

Source: http://www.rxlist.com

CREON 10 MINIMICROSPHERES (Pancrelipase Delayed-release Capsules, USP) are available in a two-piece gelatin capsule (brown opaque top half, natural transparent bottom half) imprinted in white with "SOLVAY" and "1210". Each capsule contains tan-colored delayed-release MINIMICROSPHERES of pancrelipase supplied in bottles of: 100.......NDC 0032-1210-01
250.......NDC 0032-1210-07 CREON 10 (pancrelipase delayed-released capsules) Capsules must be stored at 25ºC (77ºF); excursions permitted to 15º-30ºC (59º- 86ºF). [See USP Controlled Room Temperature.] PROTECT FROM MOISTURE. DO NOT REFRIGERATE. Dispense in tight, light-resistant containers. For human consumption only. Manufactured By: Solvay Pharmaceuticals GmbH, Hannover, Germany. Marketed by: Solvay Pharmaceuticals, Inc. Marietta, GA 30062. Rev Feb 2006. FDA Rev date: n/a Last reviewed on RxList: 9/29/2008
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

CREON 10 (pancrelipase delayed-released capsules) Capsules MINIMICROSPHERES SHOULD NOT BE CRUSHED OR CHEWED or placed on foods having a pH greater than 5.5. These can dissolve the protective enteric coating resulting in early release of enzymes, irritation of oral mucosa, and/or loss of enzyme activity. Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term studies in animals have not been performed to evaluate carcinogenic potential. Pregnancy, Category C Animal reproduction studies have not been conducted with pancrelipase. It is also not known whether pancrelipase can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. CREON 10 (pancrelipase delayed-released capsules) Capsules should be given to a pregnant woman only if clearly needed. Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when CREON 10 (pancrelipase delayed-released capsules) Capsules are administered to a nursing mother. Last reviewed on RxList: 9/29/2008
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com

Health Services in

Drug Database Online

Welcome to Senior Healthcare Matters an online drug guide and dictionary, here you can get drug information and definitaions for most popular pharmaceutical and medicinal drugs, and specifically Creon 10. Find what medications you are taking today.